Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Neoplasms 14Lung Neoplasms 10Colonic Neoplasms 10Breast Neoplasms 9Brain Neoplasms 6Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Respiratory Aspiration 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Hypoxia 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Postoperative Complications 2Patient Satisfaction 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Melanoma 2Liver Neoplasms 2Leukemia 2Delirium 2Colorectal Neoplasms 2Uterine Neoplasms 1Tuberculosis, Pulmonary 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endobronchial Metastases × Propofol × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡